COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 75 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,815,000 | -13.1% | 138,029 | 0.0% | 0.11% | -18.5% |
Q1 2019 | $2,089,000 | -28.8% | 138,029 | -19.2% | 0.13% | -42.2% |
Q4 2018 | $2,934,000 | -41.0% | 170,929 | -49.3% | 0.22% | -17.9% |
Q3 2018 | $4,973,000 | -59.0% | 337,429 | -33.7% | 0.27% | -60.2% |
Q2 2018 | $12,135,000 | +56.6% | 508,822 | +67.8% | 0.69% | +72.7% |
Q1 2018 | $7,748,000 | -27.5% | 303,222 | -47.7% | 0.40% | -18.7% |
Q4 2017 | $10,693,000 | +17.6% | 579,234 | -33.2% | 0.49% | +22.4% |
Q3 2017 | $9,092,000 | -18.7% | 866,747 | -3.0% | 0.40% | -15.8% |
Q2 2017 | $11,180,000 | +4.3% | 893,688 | -16.1% | 0.48% | -12.7% |
Q1 2017 | $10,714,000 | +0.5% | 1,065,000 | +55.5% | 0.54% | +8.8% |
Q4 2016 | $10,664,000 | +69.6% | 684,909 | +109.8% | 0.50% | +160.9% |
Q3 2016 | $6,289,000 | +228.2% | 326,500 | +102.0% | 0.19% | +143.0% |
Q2 2016 | $1,916,000 | -58.8% | 161,625 | -36.9% | 0.08% | -61.5% |
Q1 2016 | $4,649,000 | – | 256,125 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |